Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tumor necrosis factor-inducible gene 6 protein (TSG-6) is a cytokine secreted by mesenchymal stem cells (MSCs) and regulates MSC stemness. We previously reported that TSG-6 changes primary human hepatic stellate cells (pHSCs) into stem-like cells by activating yes-associated protein-1 (YAP-1). However, the molecular mechanism behind the reprogramming action of TSG-6 in pHSCs remains unknown. Cluster of differentiation 44 (CD44) is a transmembrane protein that has multiple functions depending on the ligand it is binding, and it is involved in various signaling pathways, including the Wnt/β-catenin pathway. Given that β-catenin influences stemness and acts downstream of CD44, we hypothesized that TSG-6 interacts with the CD44 receptor and stimulates β-catenin to activate YAP-1 during TSG-6-mediated transdifferentiation of HSCs. Immunoprecipitation assays showed the interaction of TSG-6 with CD44, and immunofluorescence staining analyses revealed the colocalization of TSG-6 and CD44 at the plasma membrane of TSG-6-treated pHSCs. In addition, TSG-6 treatment upregulated the inactive form of phosphorylated glycogen synthase kinase (GSK)-3β, which is a negative regulator of β-catenin, and promoted nuclear accumulation of active/nonphosphorylated β-catenin, eventually leading to the activation of YAP-1. However, CD44 suppression in pHSCs following CD44 siRNA treatment blocked the activation of β-catenin and YAP-1, which inhibited the transition of TSG-6-treated HSCs into stem-like cells. Therefore, these findings demonstrate that TSG-6 interacts with CD44 and activates β-catenin and YAP-1 during the conversion of TSG-6-treated pHSCs into stem-like cells, suggesting that this novel pathway is an effective therapeutic target for controlling liver disease.
Abstract
Tumor necrosis factor-inducible gene 6 protein (TSG-6) is a cytokine secreted by mesenchymal stem cells (MSCs) and regulates MSC stemness. We previously reported that TSG-6 changes primary human hepatic stellate cells (pHSCs) into stem-like cells by activating yes-associated protein-1 (YAP-1). However, the molecular mechanism behind the reprogramming action of TSG-6 in pHSCs remains unknown. Cluster of differentiation 44 (CD44) is a transmembrane protein that has multiple functions depending on the ligand it is binding, and it is involved in various signaling pathways, including the Wnt/β-catenin pathway. Given that β-catenin influences stemness and acts downstream of CD44, we hypothesized that TSG-6 interacts with the CD44 receptor and stimulates β-catenin to activate YAP-1 during TSG-6-mediated transdifferentiation of HSCs. Immunoprecipitation assays showed the interaction of TSG-6 with CD44, and immunofluorescence staining analyses revealed the colocalization of TSG-6 and CD44 at the plasma membrane of TSG-6-treated pHSCs. In addition, TSG-6 treatment upregulated the inactive form of phosphorylated glycogen synthase kinase (GSK)-3β, which is a negative regulator of β-catenin, and promoted nuclear accumulation of active/nonphosphorylated β-catenin, eventually leading to the activation of YAP-1. However, CD44 suppression in pHSCs following CD44 siRNA treatment blocked the activation of β-catenin and YAP-1, which inhibited the transition of TSG-6-treated HSCs into stem-like cells. Therefore, these findings demonstrate that TSG-6 interacts with CD44 and activates β-catenin and YAP-1 during the conversion of TSG-6-treated pHSCs into stem-like cells, suggesting that this novel pathway is an effective therapeutic target for controlling liver disease.
참고문헌 (32)
- Carelli S, "Mechanical Activation of Adipose Tissue and Derived Mesenchymal Stem Cells : Novel Anti-Inflammatory Properties", Int J Mol Sci, 19, pp.pii: E267~ (2018)
- Romano B, "TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells", Stem Cells, 37, pp.973~987 (2019)
- Wang S, "Tumor necrosis factorinducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse", Biomaterials, 219, pp.119375~ (2019)
- Cao H, "The role of CD44 in fetal and adult hematopoietic stem cell regulation", Haematologica, 101, pp.26~37 (2016)
- Baaten BJ, "Multifaceted regulation of T cells by CD44", Commun Integr Biol, 3, pp.508~512 (2010)
- Johnson P, "CD44 and its role in inflammation and inflammatory diseases", Inflamm Allergy Drug Targets, 8, pp.208~220 (2009)
- van der Windt GJ, "CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gramnegative pneumonia", Am J Pathol, 177, pp.2483~2494 (2010)
- Thapa R, "The Importance of CD44as a Stem Cell Biomarker and Therapeutic Target in Cancer", Stem Cells Int, 2016, pp.2087204~ (2016)
- Du L, "CD44 is of Functional Importance for Colorectal Cancer Stem Cells", Clin Cancer Res, 14, pp.6751~6760 (2008)
- Zhu H, "The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix", Stem Cells, 24, pp.928~935 (2006)
- Lesley J, "CD44 and its interaction with extracellular matrix", Adv Immunol, 54, pp.271~335 (1993)
- Bourguignon LY, "Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression", Semin Cancer Biol, 18, pp.251~259 (2008)
- Orian-Rousseau V, "Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin", Mol Biol Cell, 18, pp.76~83 (2007)
- Herishanu Y, "Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1", Leuk Lymphoma, 52, pp.1758~1769 (2011)
- Schmitt M, "CD44 functions in Wnt signaling by regulating LRP6 localization and activation", Cell Death Differ, 22, pp.677~689 (2015)
- Choi H, "Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2", NF-kappaB signaling in resident macrophages, 2011, pp.118, 330~338
- Zhan T, "Wnt signaling in cancer", Oncogene, 36, pp.1461~1473 (2017)
- Steinhart Z, "Wnt signaling in development and tissue homeostasis", Development, 145, pp.dev146589~ (2018)
- JiKui Shi, "High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin", BMB Reports, 52(7), pp.451~456 (2019), 생화학분자생물학회[DOI]
- Behrens J, "Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β", Science, 280, pp.596~599 (1998)
- He TC, "Identification of c-MYC as a target of the APC pathway", Science, 281, pp.1509~1512 (1998)
- Bottomly D, "Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq", Nucleic Acids Res, 38, pp.5735~5745 (2010)
- Konsavage WM Jr, "Wnt", beta-catenin signaling regulates Yes-associated protein(YAP)gene expression in colorectal carcinoma cells, 2012, pp.287, 11730~11739
- Miki T, "Wnt", beta-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming, 2011, pp.7, 836~846
- Chang G, "CD44 targets Wnt", beta-catenin pathway to mediate the proliferation of K562 cells, 2013, pp.13, 117~
- Zhu X, "Moesin is a glioma progression marker that induces proliferation and Wnt", betacatenin pathway activation via interaction with CD44, 2013, pp.73, 1142~1155
- Yovchev MI, "Novel hepatic progenitor cell surface markers in the adult rat liver", Hepatology, 45, pp.139~149 (2007)
- Satoh T, "Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis", J Gastroenterol Hepatol, 15, pp.402~411 (2000)
- Kikuchi S, "Role of CD44 in epithelial wound repair : migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6", J Biol Chem, 280, pp.15398~15404 (2005)
- Chen C, "The biology and role of CD44 in cancer progression : therapeutic implications", J Hematol Oncol, 11, pp.64~ (2018)
- Lesley J, "Hyaluronan binding properties of a CD44chimera containing the link module of TSG-6", J Biol Chem, 277, pp.26600~26608 (2002)
- Lesley J, "TSG-6 modulates the interaction between hyaluronan and cell surface CD44", J Biol Chem, 279, pp.25745~25754 (2004)